Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2008; 1:434-435, doi:10.1016/j.jcmg.2008.04.008
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taegtmeyer, H.
Right arrow Articles by Algahim, M. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Taegtmeyer, H.
Right arrow Articles by Algahim, M. F.
Related Collections
Right arrowRelated Article

Editorial comment

Obesity and Cardiac Metabolism in Women*

Heinrich Taegtmeyer, MD, DPhil, FACC*, Mohamed F. Algahim, BSc

Department of Internal Medicine, Division of Cardiology, the University of Texas Medical School at Houston, Houston, Texas.

Key Words: myocardial metabolism • obesity • gender • cardiac efficiency


Obesity is a vexing problem for the clinician and for the cardiovascular physiologist alike. Although we tend to blame an "obesogenic" environment, nobody really knows the cause for the current obesity epidemic. Is it the environment? Is it genes? Or is it the environment acting on certain genes? Currently approximately 6% of the American population is clinically severely obese (1) and it is well documented that obesity reduces life expectancy (2). Death and disability from heart disease feature prominently in obesity. Most importantly, the dysregulated lipid metabolism in obesity does not stop in the arterial wall. Obesity is, for example, an independent risk factor for heart failure, as defined by criteria of the Framingham study (3). The data also show that women are more likely to develop heart failure than men (14% vs. 11%). It is tempting to speculate that the gender difference can be traced to the metabolism of energy-providing substrates.

The study by Peterson et al. (4) in this issue of iJACC (JACC: Cardiovascular Imaging) suggests that this might be the case. In a series of elegantly performed tracer kinetic experiments, complemented by extensive metabolic and hemodynamic profiling, the investigators found that a pre-existing increase in myocardial blood flow and oxygen consumption (MVO2) in women was further amplified by obesity. Furthermore, both myocardial blood flow and MVO2 were directly related to body mass index in women, but not in men. In spite of greater cardiac work, the heart's efficiency (defined as cardiac work/MVO2) was less in women than in men. Because energy can neither be created nor destroyed, the results suggest impaired coupling of fatty acid oxidation to adenosine triphosphate production or futile cycling of substrates (5) in the heart of obese women. The investigators imply that uncoupling proteins are the mediators for reduced cardiac efficiency. This is a reasonable speculation; although, there is also a cardioprotective role for uncoupling proteins that needs to be considered. We have speculated that uncoupling proteins reduce the formation of reactive oxygen species (5,6) and lessen the consequences of oxidative stress on the heart.

Circulatory dysfunction in massively obese people associated with cardiac enlargement (during life and at autopsy) was first suggested in the "Munich beer heart" at the beginning of the last century (7) and again in a study on adiposity of the heart in the 1930s (8). It has long been appreciated that obesity is associated with increases in blood volume and cardiac output that are proportional to body weight and duration of obesity (9). There are also significant negative correlations between the ratio of stroke work index to the left ventricular and diastolic pressure and the amount of excess weight (10) as well as left ventricular diastolic function and plasma free fatty acid concentrations (11).

In the normal mammalian heart, free fatty acids provide the bulk of energy providing substrates (12); although, the heart exhibits a great amount of metabolic flexibility (13). This flexibility seems to be compromised when the heart is flooded with fatty acids and when the heart becomes less responsive to insulin. Although the mechanisms underlying impaired glucose uptake in the presence of fatty acids are complex, the inhibition of glucose oxidation by fatty acids at the level of the pyruvate dehydrogenase complex is undisputed. Nature seems to find ways to protect the heart muscle cell from an oversupply of fuel in the form of carbohydrates and also in the form of fatty acids. Although the mechanisms for the inhibition of glucose metabolism are relatively well understood, the heart's response to excess fatty acids is more complex. Although fatty acids contain more than twice the amount of chemical energy (by weight) than carbohydrates, the amount of usable adenosine triphosphate produced from oxidation of fatty acids is less than the amount of adenosine triphosphate derived from oxidation of glucose (14). Also, the "uncoupling" effect of fatty acid oxidation is not an entirely new observation. Earlier studies, 1 of them in vitro (15) and the other ex vivo (16), readily explain the increased MVO2 and decreased cardiac efficiency (4).

The questions remain: Are the increase in fatty acid oxidation and the decrease in cardiac efficiency cause or consequence for the presumed increased death and disability from heart failure in obese women? Is the increase in cardiac mass in obese subjects the result of true hypertrophy (synthesis of contractile proteins) or "metabolic hypertrophy" (increase in mitochondrial mass and/or endogenous substrates)? Figure 4 of the study by Peterson et al. (4) seems to suggest the latter. It would also be interesting to know how to reconcile the present findings with those of animal models of obesity that suggest the opposite gender effects: predominance of fatty acid metabolism in hearts from male rather than female animals (17). Furthermore, the variability in body composition between the obese male and obese female is significant in fat mass, percent fat, and fat-free mass, as well as a relatively larger waist circumference in women. Although these differences are consistent with the pattern of change of obesity in women (a shift from subcutaneous to visceral adiposity), should this be taken into consideration when comparing obese and nonobese women as well as men, who have a more consistent pattern of visceral adiposity throughout life? Also, visceral adiposity in women is associated with decreased skeletal muscle uptake of free fatty acids (18) and impaired left ventricular remodeling compared to that of men (19). These factors may contribute to the gender differences in myocardial fatty acid oxidation and cardiac function. Lastly, the readers would probably like to know whether the observed changes are reversible with weight loss.

In short, there is still much to be learned about the "woman's heart." It is, however, exciting to see that the tools of metabolic imaging are now sophisticated enough to address these questions. After nearly 3 decades of assessing regional differences, metabolic imaging with positron-labeled tracers is now reaching deeper and deeper into cardiac physiology and biochemistry.


    Acknowledgments
 
The authors thank Roxy A. Tate for editorial assistance.


    Footnotes
 
Supported in part by grants from the National Heart, Lung, and Blood Institute.

* Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. Back

* Reprint request and correspondence: Dr. Heinrich Taegtmeyer, Professor of Medicine, Department of Internal Medicine, Division of Cardiology, the University of Texas Medical School at Houston, 6431 Fannin, MSB 1.246, Houston, Texas 77030. (Email: Heinrich.Taegtmeyer{at}uth.tmc.edu).


    REFERENCES
 Top
 REFERENCES
 

  1. Mokdad A, Ford E, Bowman B, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors JAMA 2003;289:76-79.[Abstract/Free Full Text]
  2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr. CW. Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 1999;341:1097-1105.[Abstract/Free Full Text]
  3. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure N Engl J Med 2002;347:305-313.[Abstract/Free Full Text]
  4. Peterson LR, Soto PF, Herrero P, et al. Impact of gender on the myocardial metabolic response to obesity J Am Coll Cardiol Img 2008;1:424-433.[Abstract/Free Full Text]
  5. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats Biochem J 2007;406:457-467.[CrossRef][Web of Science][Medline]
  6. Razeghi P, Young ME, Ying J, et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading Cardiology 2002;97:203-209.[CrossRef][Web of Science][Medline]
  7. Meister HP. The "Munich beer heart"—revisited Beitr Pathol 1976;157:1-13.[Web of Science][Medline]
  8. Smith H, Willius F. Adiposity of the heart: a clinical pathologic study of 136 obese patients Arch Intern Med 1933;52:910-931.
  9. Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output Circulation 1982;66:55-60.[Abstract/Free Full Text]
  10. de Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M. Obesity and cardiac function Circulation 1981;64:477-482.[Abstract/Free Full Text]
  11. Leichman JG, Aguilar D, King TM, Vlada A, Reyes M, Taegtmeyer H. Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity Am J Clin Nutr 2006;84:336-341.[Abstract/Free Full Text]
  12. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart Biochem J 1980;186:701-711.[Web of Science][Medline]
  13. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart Ann N Y Acad Sci 2004;1015:202-213.[CrossRef][Web of Science][Medline]
  14. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo Am J Physiol Heart Circ Physiol 2000;278:H1345-H1351.[Abstract/Free Full Text]
  15. Borst P, Loos JA, Christ EJ, Slater EC. Uncoupling activity of long chain fatty acids Biochim Biophys Acta 1962;62:509-517.[Medline]
  16. Challoner D, Steinberg D. Effect of free fatty acid on the oxygen consumption of perfused rat heart Am J Physiol 1966;210:280-286.[Free Full Text]
  17. Essop MF, Chan WY, Taegtmeyer H. Metabolic gene switching in the murine female heart parallels enhanced mitochondrial respiratory function in response to oxidative stress FEBS J 2007;274:5278-5284.[CrossRef][Medline]
  18. Colberg SR, Simoneau JA, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity J Clin Invest 1995;95:1846-1853.[Web of Science][Medline]
  19. Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction Prog Cardiovasc Dis 2007;49:241-251.[CrossRef][Web of Science][Medline]

Related Article

Impact of Gender on the Myocardial Metabolic Response to Obesity
Linda R. Peterson, Pablo F. Soto, Pilar Herrero, B. Selma Mohammed, Michael S. Avidan, Kenneth B. Schechtman, Carmen Dence, and Robert J. Gropler
J. Am. Coll. Cardiol. Img. 2008 1: 424-433. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taegtmeyer, H.
Right arrow Articles by Algahim, M. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Taegtmeyer, H.
Right arrow Articles by Algahim, M. F.
Related Collections
Right arrowRelated Article

Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link